Related Experiment Video
Updated: May 5, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
A Systematic Study on Prenatal Opioid Exposure: A Review of Neurodevelopmental Consequences
1Neuroscience and Behavioral Biology Department, Emory University, Atlanta, GA; and.
Prenatal opioid exposure poses risks to neurodevelopment, particularly in neurosensory and socioemotional domains. Maternal opioid use necessitates monitoring child neurodevelopmental growth.
Area of Science:
- Neuroscience
- Developmental Psychology
- Public Health
Background:
- Prenatal opioid exposure is a growing concern with potential long-term effects on child development.
- Understanding the specific neurodevelopmental impacts is crucial for early intervention and support.
Purpose of the Study:
- To systematically review and evaluate adverse neurodevelopmental impacts linked to prenatal opioid exposure.
- To synthesize findings across various neurobehavioral and neuroimaging domains.
Main Methods:
- Systematic review adhering to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
- Inclusion of 86 studies, with evaluation using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) system.
- Results categorized into 6 neurobehavioral domains and 1 neuroimaging domain.
Main Results:
- Neurosensory domain showed the highest risk of impairment (76.9%) in children with prenatal opioid exposure.
- Socioemotional domain exhibited the largest effect size for negative impact (Hedge's g = -1.14).
- Neuroimaging studies were limited and heterogeneous, hindering definitive conclusions.
Conclusions:
- Maternal opioid use during pregnancy is a risk indicator for developmental monitoring.
- Direct teratogenic effects are difficult to ascertain due to confounding factors like co-occurring substance use and social adversity.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Teratogenicity
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners